Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions
HypertensionCardiovascular DiseasesVascular Diseases
Interventions
DEVICE

Renal Denervation (Symplicity Spyral™)

Symplicity Spyral™ multi-electrode renal denervation system

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY